Ali Health and Sanofi team up to cooperate O2O and chronic disease management
On June 1st, Ali Health and Sanofi China signed a strategic cooperation framework agreement in Shanghai. The two sides will share high-quality resources and explore the cooperation in many medical and health fields such as O2O and chronic disease management to build a safe and professional for Chinese users. Convenient medical health service network.
According to the agreement, Ali Health and Sanofi China will cooperate in various aspects of the medical and health field, and form a joint force in the business to jointly expand the market. The two parties will adhere to the principle of "patient first", take advantage of Ali's platform technology and the advantages of Sanofi in the medical and health industry, and jointly explore the O2O model of online and offline integration, and provide users within the scope permitted by policies and regulations. Provide drug-related services and support. In addition, Sanofi China will use its professional knowledge and experience of chronic diseases to provide health services to users through the Ali Health Platform.
Ma Li, vice president of Ali Health, said: "The cooperation between high-quality pharmaceutical companies and Internet companies is the future development trend. Internet technology can help doctors, pharmacists and patients to establish convenient and fast communication methods. Based on this, Ali Health Network Hospital is working Bringing high-quality medical resources from big cities to rural areas where medical care is lacking, family doctors are also playing a role as a health gatekeeper for community residents, helping patients and their families to jointly manage and monitor chronic diseases.
Mr. Peng Zhenke, General Manager of Sanofi China Pharmaceutical Operations, said: “Sinofi is committed to bringing more healthy new solutions to patients through innovative drugs and services. This time, with Ali Health, we will be based on 'patient first'. The purpose is to make full use of Sanofi's in-depth understanding of the medical industry and disease management, combined with the advantages of Ali Health's platform data technology, to achieve leap-forward cooperation, to provide scientific and professional medical health services for patients and their families."
In addition to this Ali Health and Sanofi team cooperation, previously, on April 9, 2016, AstraZeneca and Dr. Chun Yu announced a cooperation to establish an integrated chronic disease management system, including cooperation with grassroots doctors. The combination of on-line and offline training will improve the level of diagnosis and treatment in the field of chronic diseases; carry out online and offline disease education and chronic disease management for patients, improve the efficiency and viscosity of doctor-patient interaction, and improve patient compliance.
On April 18th, 2016, Xinglin and Pfizer China reached a strategic cooperation consensus, which is an efficient Internet platform for doctors in the field of severe infections to build professional growth and clinical collaboration.
Why the pharmaceutical companies and mobile medical companies frequently hold hands, the reason is that they have a common vision and purpose and complementary resources and capabilities.
According to industry insiders, well-known pharmaceutical companies are holding mobile medical companies. On the one hand, the current business philosophy or marketing concept of pharmaceutical companies is changed from disease, doctor-centered to patient-centered or to overall solutions. Among them, mobile medical companies have natural popularity and monitoring in terms of patient aggregation. On the other hand, with the trend of “+Internetâ€, pharmaceutical companies also need to explore and summarize the experience and operational concepts in this area. With the cooperation between pharmaceutical companies and mobile medical companies, this year has occurred.
In animal husbandry, there are problems such as the abuse of chemical drugs, the acceleration of virus mutation, and the emergence of drug-resistant strains, which have caused the proliferation of various epidemics and caused huge losses to the animal husbandry. To ensure food safety, it is necessary to ensure the safety of livestock and poultry products. The safety of livestock and poultry products depends on the safety of feed, and ensuring the safety of feed additives is the key to ensuring feed safety. Today, when healthy aquaculture is vigorously advocated, natural Plant Extract feed additives with non-toxic side effects, no residues, and resistance to drug resistance have very broad application prospects.
Natural plant additives are feed additives that take one or more whole plants or parts of natural plants as raw materials and are processed by physical extraction or biological fermentation to have the effects of nutrition, growth promotion, feed utilization rate improvement, and animal product quality improvement. No harm to animals, safe and non-toxic.
Plant Extract,Yucca Extract Powder,Herb Extract Powder,Feed Grade
Amazy Organic Biotech Co.,Ltd , https://www.amazyorganic.com